The Prophylactic Use of Tirofiban versus Oral Antiplatelet Medications in Stent-Assisted Coiling of Intracranial Aneurysms: A Meta-analysis

References

1. 1.↵
   1. Molyneux AJ,
   2. Birks J,
   3. Clarke A, et al

   . The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18-year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet 2015;385:691–97 doi:10.1016/S0140-6736(14)60975-2 pmid:25465111

   CrossRefPubMed
2. 2.↵
   1. De Vries J,
   2. Boogaarts J,
   3. Van Norden A, et al

   . New generation of flow diverter (SURPASS) for unruptured intracranial aneurysms: a prospective single-center study in 37 patients. Stroke 2013;44:1567–77 doi:10.1161/STROKEAHA.111.000434 pmid:23686973

   Abstract/FREE Full Text
3. 3.↵
   1. Awtry EH,
   2. Loscalzo J

   . Aspirin. Circulation 2000;101:1206–18 doi:10.1161/01.CIR.101.10.1206

   FREE Full Text
4. 4.↵
   1. Born G,
   2. Patrono C

   . Antiplatelet drugs. Br J Pharmacol 2006;147(Suppl 1):S241–51 doi:10.1038/sj.bjp.0706401 pmid:16402110

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Ries T,
   2. Buhk JH,
   3. Kucinski T, et al

   . Intravenous administration of acetylsalicylic acid in stent-assisted coiling of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006;37:1816–21 doi:10.1161/01.STR.0000226933.44962.a6 pmid:16778126

   Abstract/FREE Full Text
6. 6.↵
   1. Yamada NK,
   2. Cross DT, 3rd.,
   3. Pilgram TK, et al

   . Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007;28:1778–82 doi:10.3174/ajnr.A0641 pmid:17885244

   Abstract/FREE Full Text
7. 7.↵
   1. Hwang G,
   2. Huh W,
   3. Lee JS, et al

   . Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol 2015;72:764–72 doi:10.1001/jamaneurol.2015.0654 pmid:26010803

   CrossRefPubMed
8. 8.↵
   1. Dehdashti AR,
   2. Rilliet B,
   3. Rufenacht DA, et al

   . Shunt-dependent hydrocephalus after rupture of intracranial aneurysms: a prospective study of the influence of treatment modality. J Neurosurg 2004;101:402–07 doi:10.3171/jns.2004.101.3.0402 pmid:15352596

   CrossRefPubMed
9. 9.↵
   1. Connolly ES Jr.,
   2. Rabinstein AA,
   3. Carhuapoma JR, et al

   . American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1711–37 doi:10.1161/STR.0b013e3182587839 pmid:22556195

   Abstract/FREE Full Text
10. 10.↵
    1. Valgimigli M,
    2. Biondi-Zoccai G,
    3. Tebaldi M, et al

    . Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J 2010;31:35–49 doi:10.1093/eurheartj/ehp376 pmid:19755402

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Chalouhi N,
    2. Jabbour P,
    3. Daou B, et al

    . A new protocol for anticoagulation with tirofiban during flow diversion. Neurosurgery 2016;78:670–74 doi:10.1227/NEU.0000000000001071 pmid:26488330

    CrossRefPubMed
12. 12.↵
    1. Chalouhi N,
    2. Jabbour P,
    3. Kung D, et al

    . Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms. Neurosurgery 2012;71:710–14; discussion 714 doi:10.1227/NEU.0b013e31826213f9 pmid:22668886

    CrossRefPubMed
13. 13.↵
    1. Moher D,
    2. Liberati A,
    3. Tetzlaff J, et al

    . The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535 doi:10.1136/bmj.b2535 pmid:19622551

    FREE Full Text
14. 14.↵
    1. Slim K,
    2. Nini E,
    3. Forestier D, et al

    . Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003;73:712–16 doi:10.1046/j.1445-2197.2003.02748.x pmid:12956787

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Guyatt GH,
    2. Oxman AD,
    3. Vist GE, et al

    . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–26 doi:10.1136/bmj.39489.470347.AD pmid:18436948

    FREE Full Text
16. 16.↵
    1. DerSimonian R,
    2. Laird N

    . Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88 doi:10.1016/0197-2456(86)90046-2 pmid:3802833

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Altman DG,
    2. Bland JM

    . Interaction revisited: the difference between two estimates. BMJ 2003;326:219 doi:10.1136/bmj.326.7382.219 pmid:12543843

    FREE Full Text
18. 18.↵
    1. Liang XD,
    2. Wang ZL,
    3. Li TX, et al

    . Safety and efficacy of a new prophylactic tirofiban protocol without oral intraoperative antiplatelet therapy for endovascular treatment of ruptured intracranial aneurysms. J Neuronterv Surg 2016;8:1148–53 doi:10.1136/neurintsurg-2015-012055 pmid:26614492

    CrossRefPubMed
19. 19.↵
    1. Kim S,
    2. Choi JH,
    3. Kang M, et al

    . Safety and efficacy of intravenous tirofiban as antiplatelet premedication for stent-assisted coiling in acutely ruptured intracranial aneurysms. AJNR Am J Neuroradiol 2016;37:508–14 doi:10.3174/ajnr.A4551 pmid:26471748

    Abstract/FREE Full Text
20. 20.↵
    1. Limaye K,
    2. Zanaty M,
    3. Hudson J, et al

    . The safety and efficacy of continuous tirofiban as a monoantiplatelet therapy in the management of ruptured aneurysms treated using stent-assisted coiling or flow diversion and requiring ventricular drainage. Neurosurgery 2019;85:E1037–42 doi:10.1093/neuros/nyz226 pmid:31298301

    CrossRefPubMed
21. 21.↵
    1. Lee SH,
    2. Park IS,
    3. Lee JM, et al

    . Stent-assisted coil embolization using only a glycoprotein iib/iiia inhibitor (tirofiban) for ruptured wide-necked aneurysm repair. J Cerebrovasc Endovasc Neurosurg 2018;20:14–23 doi:10.7461/jcen.2018.20.1.14 pmid:30370235

    CrossRefPubMed
22. 22.↵
    1. Zi-Liang W,
    2. Xiao-Dong L,
    3. Tian-Xiao L, et al

    . Intravenous administration of tirofiban versus loading dose of oral clopidogrel for preventing thromboembolism in stent-assisted coiling of intracranial aneurysms. Int J Stroke 2017;12:553–59 doi:10.1177/1747493016677989 pmid:28697712

    CrossRefPubMed
23. 23.↵
    1. Soize S,
    2. Foussier C,
    3. Manceau PF, et al

    . Comparison of two preventive dual antiplatelet regimens for unruptured intracranial aneurysm embolization with flow diverter/disrupter: a matched-cohort study comparing clopidogrel with ticagrelor. J Neuroradiol 2019;46:378–83 doi:10.1016/j.neurad.2019.01.094 pmid:30731144

    CrossRefPubMed
24. 24.↵
    1. Foreman PM,
    2. Enriquez-Marulanda A,
    3. Mooney JH, et al

    . Whole blood aggregometry prior to Pipeline embolization device treatment of intracranial aneurysms: defining an optimal platelet inhibition cutoff value for clopidogrel. J Neurosurg 2018 Nov 1. [Epub ahead of print] doi:10.3171/2018.6.JNS181044] pmid:30497139

    CrossRefPubMed
25. 25.↵
    1. Park SH,
    2. Kim YB,
    3. Huh SK

    . Effect of premedication method and drug resistance of antiplatelet agent on periprocedural thromboembolic events during coil embolization of an unruptured intracranial aneurysm. J Cerebrovasc Endovasc Neurosurg 2012;14:148– 56 doi:10.7461/jcen.2012.14.3.148 pmid:23210040

    CrossRefPubMed
26. 26.↵
    1. Hudson JS,
    2. Nagahama Y,
    3. Nakagawa D, et al

    . Hemorrhage associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on a regimen of dual antiplatelet therapy: a retrospective analysis. J Neurosurg 2018;129:916–21 doi:10.3171/2017.5.JNS17642 pmid:29125410

    CrossRefPubMed
27. 27.↵
    1. Hwang G,
    2. Jung C,
    3. Park SQ, et al

    . Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication. Neurosurgery 2010;67:743–48; discussion 748 doi:10.1227/01.NEU.0000374770.09140.FB pmid:20651627

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Atallah E,
    2. Saad H,
    3. Bekelis K, et al

    . Safety and efficacy of a 600-mg loading dose of clopidogrel 24 hours before Pipeline Embolization Device treatment. World Neurosurg 2017;106:529–35 doi:10.1016/j.wneu.2017.07.019 pmid:28712897

    CrossRefPubMed
29. 29.↵
    1. Peret A,
    2. Mine B,
    3. Bonnet T, et al

    . Safety and efficacy of a pre-treatment antiplatelet regimen of unruptured intracranial aneurysms: a single-center experience. Neuroradiology 2020;62:1029–41 doi:10.1007/s00234-020-02387-y pmid:3217037

    CrossRefPubMed
30. 30.↵
    1. Moore JM,
    2. Adeeb N,
    3. Shallwani H, et al

    . A multicenter cohort comparison study of the safety, efficacy, and cost of ticagrelor compared to clopidogrel in aneurysm flow diverter procedures. Neurosurgery 2017;81:665–71 doi:10.1093/neuros/nyx079 pmid:28475757

    CrossRefPubMed
31. 31.↵
    1. Chalouhi N,
    2. Jabbour P,
    3. Singhal S, et al

    . Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke 2013;44:1348–53 doi:10.1161/STROKEAHA.111.000641 pmid:3512976

    Abstract/FREE Full Text
32. 32.↵
    1. Brinjikji W,
    2. Murad MH,
    3. Lanzino G, et al

    . Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442–47 doi:10.1161/STROKEAHA.112.678151 pmid:23321438

    Abstract/FREE Full Text
33. 33.↵
    1. Lessne ML,
    2. Shah P,
    3. Alexander MJ, et al

    . Thromboembolic complications after Neuroform stent-assisted treatment of cerebral aneurysms: the Duke Cerebrovascular Center experience in 235 patients with 274 stents. Neurosurgery 2011;69:369–75 doi:10.1227/NEU.0b013e31821bc49c pmid:21499154

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Tumialan LM,
    2. Zhang YJ,
    3. Cawley CM, et al

    . Intracranial hemorrhage associated with stent-assisted coil embolization of cerebral aneurysms: a cautionary report. J Neurosurg 2008;108:1122–29 doi:10.3171/JNS/2008/108/6/1122 pmid:18518714

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Rahme RJ,
    2. Zammar SG,
    3. El Ahmadieh TY, et al

    . The role of antiplatelet therapy in aneurysm coiling. Neurol Res 2014;36:383–88 doi:10.1179/1743132814Y.0000000317 pmid:24617939

    CrossRefPubMed
36. 36.↵
    1. Scarborough RM,
    2. Kleiman NS,
    3. Phillips DR

    . Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? Circulation 1999;100:437–44 doi:10.1161/01.CIR.100.4.437 pmid:10421606

    Abstract/FREE Full Text
37. 37.↵
    1. Topol EJ,
    2. Byzova TV,
    3. Plow EF

    . Platelet GPIIb-IIIa blockers. Lancet 1999;353:227– 31 doi:10.1016/S0140-6736(98)11086-3 pmid:9923894

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Yi HJ,
    2. Gupta R,
    3. Jovin TG, et al

    . Initial experience with the use of intravenous eptifibatide bolus in stent-assisted coiling of intracranial aneurysms. AJNR Am J Neuroradiol 2006;27:1856–60 pmid:17032856

    Abstract/FREE Full Text
39. 39.↵
    1. Jeong HW,
    2. Jin SC

    . Intra-arterial infusion of a glycoprotein IIb/IIIa antagonist for the treatment of thromboembolism during coil embolization of intracranial aneurysm: a comparison of abciximab and tirofiban. AJNR Am J Neuroradiol 2013;34:1621–25 doi:10.3174/ajnr.A3501 pmid:23660289

    Abstract/FREE Full Text
40. 40.↵
    1. McClellan KJ,
    2. Goa KL

    . Tirofiban. A review of its use in acute coronary syndromes. Drugs 1998;56:1067–80 doi:10.2165/00003495-199856060-00017 pmid:9878994

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Steinhubl SR,
    2. Talley JD,
    3. Braden GA, et al

    . Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 2001;103:2572–78 doi:10.1161/01.CIR.103.21.2572 pmid:11382726

    Abstract/FREE Full Text
42. 42.↵
    1. Kirma C,
    2. Erkol A,
    3. Pala S, et al

    . Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cathet Cardiovasc Intervent 2012;79:59–67 doi:10.1002/ccd.23109 pmid:21523892

    CrossRefPubMed
43. 43.↵
    1. Wallentin L,
    2. Becker RC,
    3. Budaj A, et al

    . Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045–57 doi:10.1056/NEJMoa0904327 pmid:19717846

    CrossRefPubMedWeb of Science
44. 44.↵
    1. Gimbel M,
    2. Qaderdan K,
    3. Willemsen L, et al

    . Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet 2020;395:1374–81 doi:10.1016/S0140-6736(20)30325-1 pmid:32334703

    CrossRefPubMed
45. 45.↵
    1. Adeeb N,
    2. Griessenauer CJ,
    3. Foreman PM, et al

    . Use of platelet function testing before Pipeline embolization device placement: a multicenter cohort study. Stroke 2017;48:1322–30 doi:10.1161/STROKEAHA.116.015308 pmid:28411263

    Abstract/FREE Full Text
46. 46.↵
    1. Anderson KM,
    2. Califf RM,
    3. Stone GW, et al

    . Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2001;37:2059–65 doi:10.1016/S0735-1097(01)01290-6 pmid:11419888

    FREE Full Text
47. 47.↵
    1. Lincoff AM,
    2. Califf RM,
    3. Topol EJ

    . Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol 2000;35:1103–15 doi:10.1016/S0735-1097(00)00554-4 pmid:10758948

    FREE Full Text